Keyword: experimental drugs


Gilead to Buy Liver Drugmaker CymaBay for $4.3 Billion

13.02.2024 -

US biopharmaceutical company Gilead Sciences is to acquire CymaBay Therapeutics for $4.3 billion. Gilead offered to purchase all outstanding shares of CymaBay for $32.50...


Drugmakers, Academics Pool R&D in $265 Million EU Project

07.02.2013 - Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...